Ifp Advisors, Inc Biotechnology

Ifp Advisors, Inc

$3.07 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
IMNM Immunome Inc.	$104M	$0 0.0% of portfolio	0	Q1 2025 New
IMVT Immunovant, Inc.	$3.55B	$0 0.0% of portfolio	0	Q1 2025 New
INVA Innoviva, Inc.	$1.36B	$0 0.0% of portfolio	0	Q1 2025 New
INZY Inozyme Pharma, Inc.	$161M	$0 0.0% of portfolio	1	Q4 2024 New
IOVA Iovance Biotherapeutics, Inc.	$317M	$0 0.0% of portfolio	0	Q1 2025 New
ITOS I Teos Therapeutics, Inc.	$358M	$0 0.0% of portfolio	28	Q4 2024 New
JANX Janux Therapeutics, Inc.	$998M	$0 0.0% of portfolio	1	Q4 2024 New
KALV Kal Vista Pharmaceuticals, Inc.	$392M	$0 0.0% of portfolio	4	Q4 2024 New
KMPH Kempharm, Inc	$170M	$0 0.0% of portfolio	0	Q1 2025 New
KYMR Kymera Therapeutics, Inc.	$2.46B	$0 0.0% of portfolio	0	Q1 2025 New
LGND Ligand Pharmaceuticals Inc	$2.14B	$0 0.0% of portfolio	9	Q1 2025 New
LCTX Lineage Cell Therapeutics, Inc.	$166M	$0 0.0% of portfolio	3	Q4 2024 New
LQDA Liquidia Corp	$801M	$0 0.0% of portfolio	0	Q1 2025 New
MGNX Macrogenics Inc	$86M	$0 0.0% of portfolio	0	Q1 2025 New
MNKD Mannkind Corp	$1.04B	$0 0.0% of portfolio	12	Q4 2024 New
MRVI Maravai Lifesciences Holdings, Inc.	$351M	$0 0.0% of portfolio	0	Q1 2025 New
MDXG Mimedx Group, Inc.	$736M	$0 0.0% of portfolio	11	Q4 2024 New
GLUE Monte Rosa Therapeutics, Inc.	$232M	$0 0.0% of portfolio	0	Q1 2025 New
NUVL Nuvalent, Inc.	$3.35B	$0 0.0% of portfolio	0	Q1 2025 New
NUVB Nuvation Bio Inc.	$452M	$0 0.0% of portfolio	50	Q4 2024 New
OCUL Ocular Therapeutix, Inc	$770M	$0 0.0% of portfolio	0	Q1 2025 New
OLMA Olema Pharmaceuticals, Inc.	$185M	$0 0.0% of portfolio	0	Q1 2025 New
ORIC Oric Pharmaceuticals, Inc.	$426M	$0 0.0% of portfolio	12	Q4 2024 New
OVID Ovid Therapeutics Inc.	$29.6M	$0 0.0% of portfolio	8	Q4 2024 New
PTCT Ptc Therapeutics, Inc.	$3.54B	$0 0.0% of portfolio	8	Q4 2024 New
PMCB Pharma Cyte Biotech, Inc.	$23.4M	$0 0.0% of portfolio	1	Q1 2025 New
PHAT Phathom Pharmaceuticals, Inc.	$344M	$0 0.0% of portfolio	2	Q4 2024 New
PLRX Pliant Therapeutics, Inc.	$58.9M	$0 0.0% of portfolio	0	Q1 2025 New
PSTX Poseida Therapeutics, Inc.	$815M	$0 0.0% of portfolio	0	Q1 2025 New
PGEN Precigen, Inc.	$341M	$0 0.0% of portfolio	5	Q4 2024 New
PBYI Puma Biotechnology, Inc.	$160M	$0 0.0% of portfolio	14	Q4 2024 New
PYXS Pyxis Oncology, Inc.	$40M	$0 0.0% of portfolio	17	Q4 2024 New
RGNX Regenxbio Inc.	$376M	$0 0.0% of portfolio	24	Q4 2024 New
RLAY Relay Therapeutics, Inc.	$439M	$0 0.0% of portfolio	0	Q1 2025 New
REPL Replimune Group, Inc.	$556M	$0 0.0% of portfolio	4	Q4 2024 New
RVNC Revance Therapeutics, Inc.	$212M	$0 0.0% of portfolio	0	Q1 2025 New
SVRA Savara Inc	$261M	$0 0.0% of portfolio	0	Q1 2025 New
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	0	Q1 2025 New
SNDX Syndax Pharmaceuticals Inc	$557M	$0 0.0% of portfolio	0	Q1 2025 New
TARS Tarsus Pharmaceuticals, Inc.	$1.07B	$0 0.0% of portfolio	1	Q4 2024 New
TERN Terns Pharmaceuticals, Inc.	$167M	$0 0.0% of portfolio	0	Q1 2025 Sold Out
THRD Third Harmonic Bio, Inc.	$219M	$0 0.0% of portfolio	0	Q1 2025 New
TVTX Travere Therapeutics, Inc.	$1.09B	$0 0.0% of portfolio	17	Q4 2024 New
TCRX T Scan Therapeutics, Inc.	$32.4M	$0 0.0% of portfolio	7	Q4 2024 New
TSVT 2seventy Bio, Inc.	$189M	$0 0.0% of portfolio	0	Q1 2025 New
RARE Ultragenyx Pharmaceutical Inc.	$2.05B	$0 0.0% of portfolio	0	Q1 2025 New
VNDA Vanda Pharmaceuticals Inc.	$277M	$0 0.0% of portfolio	10	Q4 2024 New
VTYX Ventyx Biosciences, Inc.	$115M	$0 0.0% of portfolio	7	Q4 2024 New
VCYT Veracyte, Inc.	$1.91B	$0 0.0% of portfolio	22	Q1 2025 Reduced 60.0%
VERU Veru Inc.	$48.1M	$0 0.0% of portfolio	100	Q4 2024 Reduced 66.67%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.